Tag: Robert J. Coury

Biocon Biologics wraps up $3.3bn acquisition of Viatris biosimilars unit

businessnewstoday- November 30, 2022

Biocon said that its subsidiary Biocon Biologics has wrapped up the previously announced $3.3 billion acquisition of the biosimilars business of US-based pharma company Viatris. ... Read More

FTC gives conditional approval to Mylan’s acquisition of Upjohn from Pfizer

pharmanewsdaily- October 31, 2020

The US Federal Trade Commission (FTC) has granted conditional approval for Dutch pharma company Mylan’s acquisition of Upjohn, the off-patent branded and generic established medicines ... Read More